BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

520 related articles for article (PubMed ID: 14767435)

  • 1. Amb a 1-immunostimulatory oligodeoxynucleotide conjugate immunotherapy decreases the nasal inflammatory response.
    Tulic MK; Fiset PO; Christodoulopoulos P; Vaillancourt P; Desrosiers M; Lavigne F; Eiden J; Hamid Q
    J Allergy Clin Immunol; 2004 Feb; 113(2):235-41. PubMed ID: 14767435
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Amb a 1-immunostimulatory oligodeoxynucleotide conjugate immunotherapy increases CD4+CD25+ T cells in the nasal mucosa of subjects with allergic rhinitis.
    Asai K; Foley SC; Sumi Y; Yamauchi Y; Takeda N; Desrosiers M; Lavigne F; Hamid Q
    Allergol Int; 2008 Dec; 57(4):377-81. PubMed ID: 18797179
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Local induction of a specific Th1 immune response by allergen linked immunostimulatory DNA in the nasal explants of ragweed-allergic subjects.
    Tulic MK; Christodoulopoulos P; Fiset PO; Vaillancourt P; Lavigne F; Marshall JD; Van Nest G; Eiden JJ; Hamid Q
    Allergol Int; 2009 Dec; 58(4):565-72. PubMed ID: 19776676
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selective immune redirection in humans with ragweed allergy by injecting Amb a 1 linked to immunostimulatory DNA.
    Simons FE; Shikishima Y; Van Nest G; Eiden JJ; HayGlass KT
    J Allergy Clin Immunol; 2004 Jun; 113(6):1144-51. PubMed ID: 15208597
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunotherapy with a ragweed-toll-like receptor 9 agonist vaccine for allergic rhinitis.
    Creticos PS; Schroeder JT; Hamilton RG; Balcer-Whaley SL; Khattignavong AP; Lindblad R; Li H; Coffman R; Seyfert V; Eiden JJ; Broide D;
    N Engl J Med; 2006 Oct; 355(14):1445-55. PubMed ID: 17021320
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sublingual immunotherapy in patients with allergic rhinoconjunctivitis caused by ragweed pollen.
    Skoner D; Gentile D; Bush R; Fasano MB; McLaughlin A; Esch RE
    J Allergy Clin Immunol; 2010 Mar; 125(3):660-6, 666.e1-666.e4. PubMed ID: 20153030
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Grass pollen immunotherapy: symptomatic improvement correlates with reductions in eosinophils and IL-5 mRNA expression in the nasal mucosa during the pollen season.
    Wilson DR; Nouri-Aria KT; Walker SM; Pajno GB; O'Brien F; Jacobson MR; Mackay IS; Durham SR
    J Allergy Clin Immunol; 2001 Jun; 107(6):971-6. PubMed ID: 11398073
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Allergen-specific T cell responses to immunotherapy monitored by CD154 and intracellular cytokine expression.
    Campbell JD; Buchmann P; Kesting S; Cunningham CR; Coffman RL; Hessel EM
    Clin Exp Allergy; 2010 Jul; 40(7):1025-35. PubMed ID: 20412135
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and safety of oral immunotherapy with short ragweed extract.
    Van Deusen MA; Angelini BL; Cordoro KM; Seiler BA; Wood L; Skoner DP
    Ann Allergy Asthma Immunol; 1997 Jun; 78(6):573-80. PubMed ID: 9207721
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nasal immunotherapy in weed-induced allergic rhinitis.
    Gaglani B; Borish L; Bartelson BL; Buchmeier A; Keller L; Nelson HS
    Ann Allergy Asthma Immunol; 1997 Sep; 79(3):259-65. PubMed ID: 9305235
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and safety of subcutaneous immunotherapy with a biologically standardized extract of Ambrosia artemisiifolia pollen: a double-blind, placebo-controlled study.
    Mirone C; Albert F; Tosi A; Mocchetti F; Mosca S; Giorgino M; Pecora S; Parmiani S; Ortolani C
    Clin Exp Allergy; 2004 Sep; 34(9):1408-14. PubMed ID: 15347374
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunoreactivity profile of peripheral blood mononuclear cells from patients with ragweed-induced allergic rhinitis.
    Sun J; Wong B; Cundall M; Goncharova S; Conway M; Dalrymple A; Coyle AJ; Waserman S; Jordana M
    Clin Exp Allergy; 2007 Jun; 37(6):901-8. PubMed ID: 17517104
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cry j 1-induced synthesis of interleukin-5 and interferon-gamma by peripheral blood mononuclear cells of patients with seasonal allergic rhinitis due to Japanese cedar pollens.
    Nakai Y; Ohashi Y; Tanaka A; Kakinoki Y; Washio Y; Masamoto T; Yamada K; Nakai Y; Ohmoto Y
    Acta Otolaryngol Suppl; 1998; 538():143-51. PubMed ID: 9879414
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fluticasone propionate aqueous nasal spray reduces inflammatory cells in unchallenged allergic nasal mucosa: effects of single allergen challenge.
    Holm A; Dijkstra M; Kleinjan A; Severijnen LA; Boks S; Mulder P; Fokkens W
    J Allergy Clin Immunol; 2001 Apr; 107(4):627-33. PubMed ID: 11295650
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combined diesel exhaust particulate and ragweed allergen challenge markedly enhances human in vivo nasal ragweed-specific IgE and skews cytokine production to a T helper cell 2-type pattern.
    Diaz-Sanchez D; Tsien A; Fleming J; Saxon A
    J Immunol; 1997 Mar; 158(5):2406-13. PubMed ID: 9036991
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Advances in upper airway diseases and allergen immunotherapy.
    Nelson HS
    J Allergy Clin Immunol; 2007 Apr; 119(4):872-80. PubMed ID: 17292953
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Conjugation of immunostimulatory DNA to the short ragweed allergen amb a 1 enhances its immunogenicity and reduces its allergenicity.
    Tighe H; Takabayashi K; Schwartz D; Van Nest G; Tuck S; Eiden JJ; Kagey-Sobotka A; Creticos PS; Lichtenstein LM; Spiegelberg HL; Raz E
    J Allergy Clin Immunol; 2000 Jul; 106(1 Pt 1):124-34. PubMed ID: 10887315
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Randomized controlled trial of a ragweed allergy immunotherapy tablet in North American and European adults.
    Creticos PS; Maloney J; Bernstein DI; Casale T; Kaur A; Fisher R; Liu N; Murphy K; Nékám K; Nolte H
    J Allergy Clin Immunol; 2013 May; 131(5):1342-9.e6. PubMed ID: 23622121
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of nasal immunohistology in patients with seasonal rhinoconjunctivitis treated with topical steroids or specific allergen immunotherapy.
    Rak S; Heinrich C; Scheynius A
    Allergy; 2005 May; 60(5):643-9. PubMed ID: 15813810
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IL-9 and c-Kit+ mast cells in allergic rhinitis during seasonal allergen exposure: effect of immunotherapy.
    Nouri-Aria KT; Pilette C; Jacobson MR; Watanabe H; Durham SR
    J Allergy Clin Immunol; 2005 Jul; 116(1):73-9. PubMed ID: 15990777
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.